Antibody Technologies Market Research Reports & Industry Analysis
Antibody technologies involve the use of specialized proteins called antibodies to target and detect specific molecules, often used in medical diagnostics, therapeutics, and research. This field is evolving quickly due to scientific advancements and the growing demand for personalized treatments. To help you stay updated on the latest developments, MarketResearch.com offers a comprehensive collection of reports on antibody technologies.
Valuable Antibody Technologies Research and Analysis
- Find detailed data on various market segments including precision medicine, biosimilars, biologics, protein engineering, and more.
- Obtain antibody technologies market sizing and growth projections, discussions of key drivers and challenges, pricing and regulatory analysis, and company profiles.
- Read expert commentary on recent technological innovations and industry trends to gain a clear understanding of emerging opportunities.
Your Research Partner
Whether you're an experienced industry professional, a consultant, or a busy executive, our antibody technologies market research reports are designed to help you make informed decisions. With reliable data and thorough analyses, these reports support your decision-making process. By choosing MarketResearch.com, you can gain the intelligence needed to stay competitive and take advantage of new opportunities.
Antibody Technologies Industry Research & Market Reports
-
Biosimilars Market, By Drug Class (Recombinant Human Growth Hormone, Granulocyte Colony-Stimulating Factor, Insulin, Anticoagulants, Fusion Proteins Erythropoietin, Monoclonal Antibodies, Follitropin, Others), By Therapy Type (Oncology, Immunology, Hematology, Hormone Therapy, Metabolic Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Global biosimilars market growth is driven by rising healthcare costs worldwide and the expiration of blockbuster ... Read More
-
Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Global Forecast to 2029
... are designed to enhance the immune response or modulate the immune system's regulatory mechanisms, thereby enabling the body to effectively target and eliminate disease-causing agents or cellsThe immunotherapy drugs market is projected to grow from ... Read More
-
Peptide Microarray Market Size, Share & Trends Analysis Report By Type (Reagents, Services), Application (Disease Diagnostics, Protein Functional Analysis), By End Use, By Region, And Segment Forecasts, 2024 - 2030
... Trends The global peptide microarray market size is expected to reach USD 427.3 million by 2030, registering a CAGR of 6.18% from 2024 to 2030, according to a new report by Grand View Research, Inc. ... Read More
-
PCSK9 Inhibitor Market (Drug Type: Alirocumab, Evolocumab, Inclisiran, and Tafolecimab; and Modality: Fully-humanized Monoclonal Antibodies and siRNA) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... TMR’s report on the global PCSK9 inhibitor market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from ... Read More
-
Global Primary Immunodeficiency Therapeutics Market 2024-2028
... forecast period. The report on the primary immunodeficiency therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Fill-Finish Manufacturing Market Assessment, By Product Type [Consumables, Instruments], By Modality [Recombinant Proteins, Monoclonal Antibodies, Vaccines, Cell Therapies and Biological Therapies, Gene Therapies, and Others], By End-user [Contract Manufacturing Companies, Pharmaceutical and Biopharmaceutical Companies, Others], By Region, Opportunities and Forecast, 2017-2031F
... By Region, Opportunities and Forecast, 2017-2031F Global fill-finish manufacturing market is projected to witness a CAGR of 9.17% during the forecast period 2024-2031F, growing from USD 11.74 billion in 2023 to USD 23.68 billion in ... Read More
-
Global Immunosuppressants Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Global Protein A Resin Market 2024-2028
... forecast period. The report on the protein A resin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Global Breast Cancer Monoclonal Antibodies Market 2024-2028
... on the breast Cancer monoclonal antibodies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Antibody Drug Conjugates Global Market Opportunities And Strategies To 2033
... Lung Cancer; Brain Tumor4) By End User: Hospital; Clinics; Specialty CentersCovering: F. Hoffmann-La Roche Ltd.; Daiichi Sankyo Company Limited; Seagen Inc.; Gilead Sciences Inc.; Genmab Antibody Drug Conjugates Global Market Opportunities And Strategies To 2033 ... Read More
-
Ion Channel Modulators
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Channel Blockers, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$12.4 Billion by ... Read More
-
Intravenous Immunoglobulin (IVIg)
... by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. IgA, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$13.7 Billion by the ... Read More
-
Cell Surface Markers
... by 2030, growing at a CAGR of 9.2% over the analysis period 2023-2030. Antibodies, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$981.1 Million by the ... Read More
-
Antibody Drug Conjugate - Market Insights, Competitive Landscape, and Market Forecast - 2030
... And Others), End-User (Hospitals And Specialty Cancer Centers, Biotechnology And Pharmaceutical Companies, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till ... Read More
-
Global Rituxan (Rituximab) Monoclonal Antibody Market Research Report 2024(Status and Outlook)
... and older with mature B-cell Non-Hodgkin's Lymphoma (NHL) and mature B-cell acute leukemia (B-AL): in combination with chemotherapy medicines. The Global Rituxan (Rituximab) Monoclonal Antibody Market Size was estimated at USD 4326.07 million in 2023 ... Read More
-
Global Biosimilar Monoclonal Antibody Market Research Report 2024(Status and Outlook)
... produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies. Biosimilar Monoclonal Antibodies refer to the biologic ... Read More
-
Monoclonal Antibodies
... at a CAGR of 6.8% over the analysis period 2023-2030. Human-sourced Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$105.2 Billion by the end ... Read More
-
Research ELISA (Enzyme-Linked Immunosorbent Assay)
... is expected to reach US$692.3 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.5% ... Read More
-
Protein Engineering Market Report by Product & Services (Instruments, Reagents, Services and Software), Protein Type (Insulin, Monoclonal Antibodies, Coagulation Factors, Vaccines, Growth Factors, and Others), Technology (Irrational Protein Design, Rational Protein Design), End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations), and Region 2024-2032
... and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations), and Region 2024-2032 The global protein engineering market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.8 ... Read More
-
Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030
... America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of chronic diseases such as cancer, diabetes, and other autoimmune disorders, ... Read More
-
Biosensors
... of 7.1% over the analysis period 2023-2030. Non-wearable Biosensors, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$25.9 Billion by the end of the analysis period. ... Read More
-
Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material
... 2024-2035. Bioreactors represent specialized vessels employed in upstream biomanufacturing to foster the growth of cells and tissues under precisely controlled conditions. These conditions encompass factors like temperature, pH, pressure, aeration, and nutrient levels, all aimed ... Read More
-
Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications
... during the forecast period 2024-2035. Rare kidney diseases encompass a spectrum of conditions, accounting to at least 150 distinct disorders. In Europe, a condition is deemed rare if its prevalence falls below 1 in 2000 ... Read More
-
Gene Therapy Market Report by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide Gene, Deficiency, Growth Factors, Receptors, and Others), Vector Type (Viral Vector, Non-Viral Techniques), Delivery Method (In-Vivo Gene Therapy, Ex-Vivo Gene Therapy), Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Others), and Region 2024-2032
... Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Others), and Region 2024-2032 The global gene therapy market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach ... Read More
-
COVID-19 Testing
... at a CAGR of -16.1% over the analysis period 2023-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.9% CAGR and reach US$3.9 Billion by the end ... Read More
Research Assistance
